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Background: Pulmonary sclerosing hemangioma (SH) is an uncommon tumor. The aim of this study was to
identify the origin of pulmonary SH and summarize its clinicopathologic features.
Methods: Data of 26 cases of pulmonary SH were collected and reviewed, including their clinical symptoms, chest
radiological examinations, treatments, and pathological findings.
Results: Female patients of pulmonary SH were markedly frequent (n=23, 88.46%). Solitary mass or nodule in the
lung fields was the most common manifestation (n=24, 92.31%), especially in the right middle lobe (n=9, 34.62%).
There were two kinds of tumor cells: lining cells and round cells. All tumors contained a mixture of papillary, solid,
sclerotic, and hemorrhagic patterns. Immunohistochemistry with a variable number of antibodies was performed for
some cases. All of the detected specimens revealed strong reaction of lining cells with epithelial markers, such as
thyroid transcription factor-1 (TTF-1), epithelial membrane antigen (EMA), cytokeratin (CK), pancytokeratin (PCK),
and cytokeratin 7 (CK-7), while round cells were positive with TTF-1 and EMA. Until the end of last contact, none of
the patients died or suffered from the recurrence of the disease after surgical treatment.
Conclusions: Pulmonary SH is a unique neoplasm of the lung with a characteristic solitary mass or nodule.
Pulmonary epithelium might be the primary origin of the tumor cells.
Keywords: Lung neoplasms, Sclerosing hemangioma, Immunohistochemistry, Thyroid transcription factor-1 (TTF-1),
Epithelial membrane antigen (EMA), Cytokeratin (CK)Background
Pulmonary sclerosing hemangioma (SH) is a rare neo-
plasm, which was described by Liebow and Hubbell over
50 years ago [1]. Though it was generally regarded as a
benign tumor, its histogenesis and biologic behaviors is
still a controversy [2-7]. Additionally, notwithstanding the
original term of ‘sclerosing hemangioma’, more and more
evidence suggested it might not be derived from vascular-
endothelium [4-6]. Here, we reviewed 26 cases of pulmon-
ary SH patients, including their clinical manifestations,
radiological findings, treatments, and pathological results,
to explore and summarize its characteristics.
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Patients and tissue samples
A total of 26 surgically resected and histopathological
examination confirmed pulmonary SH cases, in the
Department of Thoracic and Cardiovascular Surgery,
West China Hospital of Sichuan University, China, during
the period January 2009 to May 2012, were recruited to
this study. Clinical data, such as symptoms, signs, radio-
logical examinations, and treatments, were reviewed from
the patients’ charts. Institutional review board approval for
the research was obtained from the Ethics Committee of
Sichuan University. Consent was obtained from all patients.Immunohistochemical staining
All tumor tissues were embedded in the paraffin blocks
after being fixed by 4% neutral formaldehyde, and the
following slices were approximately 4 μm. Hematoxylin-
eosin stainings were the basis for the diagnosis. Furthertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tissues from 13 subjects using the avidin-biotin method to
confirm the origin of the tumors. The mouse monoclonal
antibodies included: epithelial membrane antigen (EMA,
Dako (Dako North America Inc., CA, USA), 1:100), pan-
cytokeratin (PCK, Dako, 1:100), cytokeratin (CK, Dako,
1:100), cytokeratin 7 (CK-7, Dako, 1:100), thyroid tran-
scription factor-1 (TTF-1, Dako, 1:100), desmin (Dako,
1:100), synaptophysin (Syn, Dako, 1:100), chromogranin
(CgA, Dako, 1:100), S-100 protein (Dako, 1:100), neuron-
specific enolase (NSE, Dako, 1:100), and Ki-67 (Dako,
1:100). Deparaffinized sections were treated with methanol
containing 3% hydrogen peroxide for 10 min before
conducting antigen retrieval using a microwave oven at
95°C for 5 min and cooling at 25°C for 2 h. The sections
were incubated with target antibodies overnight at 4°C.
After washing with phosphate buffer saline (PBS), a biotin-
marked secondary antibody was applied for 10 min
followed by a peroxidase-marked streptavidin for an add-
itional 10 min. The reaction was visualized by using 3,
3’-diaminobenzidine tetrahydrochloride. Finally, the sec-
tions were counterstained with Harris hematoxylin,
dehydrated and cleared in xylene, and mounted [8].
External or internal tissues known to express the target
proteins were used as positive controls, while negative
controls referred to those whose primary antibodies were
replaced by PBS.
Immunohistochemical assessment
Expression of each marker was assessed semi-quantitatively


















No enhancement 2fraction and intensity of immunostaining of tumor cells in-
volved. The fraction score was defined as the average of five
randomly selected fields in light microscope: 0, no cell
stained; 1, <20% of cells stained; 2, 20% to 50% of cells
stained; and 3, >50% of cells stained. The intensity scores
were defined as follows: 0, no appreciable staining in the
tumor cells; 1, barely detectable staining in the cytoplasm
and/or nucleus compared with the stromal elements; 2,
readily appreciable brown staining; and 3, dark brown stain-
ing in tumor cells obscuring the cytoplasm and/or nucleus.
The total score was calculated by multiplying the fraction
score and the intensity score producing a total range from
0 to 9. For the final analysis, total scores of 0 to 2 were con-
sidered negative/low expression, and scores of 2 to 9 posi-
tive/high expression [9,10]. All histopathological evaluation
was carried out by two board-certified pathologists with
more than 5 years of experience.
Results
Clinical characteristics
Details of the clinical characteristics of the study cohort
are summarized in Table 1. Among the 26 cases, there
were 23 women and only 3 men, indicating a female:male
ratio of 7.67:1. The patients ranged in age from 31 to 68
years, with a median age of 46 years. The most frequent
symptoms were cough and sputum (n=11, 42.31%). Eight
patients (30.77%) had hemoptysis, seven of whom were
characterized by repeated bloody sputum, whereas the
remaining patient was spitting up full of blood. However,
another nine patients (34.62%) were reported to have lesions
accidentally found by routine chest X-ray examinationsCharacteristics Cases (n)
Lesion location
Left upper lobe 3
Left lower lobe 5
Right middle lobe 9
Right left lobe 6
Right middle and lower mediastinal 1
Left upper and lower lobes 1
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in physical examinations. As for past medical histories,
only one 64-year old female patient had smoked for >20
years, nearly six cigarettes per day.
All patients had chest computed tomography (CT)
scans. Most tumors (n=15, 57.69%) were located in the
right lung, especially in the middle lobe (n=9, 34.62%).
The typical radiological appearance was a solitary nodule
(9 cases, with diameters >20 mm) or mass (17 cases,
with diameters >20 mm). However, in one patient, there
were multiple distinct nodules in the bilateral lower
lobes. Another case was presented with two masses in
the upper and lower lobes of the left lung, but only the
latter was confirmed with pulmonary SH in the follow-
ing pathological examination. A right middle and lower
mediastinal mass was unique. The mean long-axis diam-
eter for the SH lesions was 29.23 mm, ranging from 10
mm to 72 mm. Apart from one lesion with an irregular
shape, two had fuzzy boundaries, and another one with
short spiculation, the remaining 22 cases (84.62%) had
round or round-like tumors with smooth margins
(Figure 1). Compared with multiple spots and flake cal-
cification in two masses, the internal texture for the
remaining lesions on normal CT scans was homoge-
neous, though there was some marginal calcification in
one mass. Lymph node enlargement in the left hilar was
found in another case. Enhanced CT scans were admin-
istrated for 11 patients, only two (2/11=18.18%) without
any enhancement.
In order to make an accurate diagnosis, 15 patients re-
ceived fiberoptic bronchosocopy examinations before
surgeries, but they all indicated chronic inflammation
without evidence of tumors.
According to the existing clinical data mentioned
above, only one patient was diagnosed with pulmonary
SH; the other initial diagnoses were lung cancer (n=10,
38.46%), tuberculoma (n=4, 15.38%), inflammatoryFigure 1 One mass of approximately 58.2 mm in the left lung
with a smooth margin.nodule (n=1, 3.85%), other benign lesions (n=7, 26.92%),
and undetermined (n=3, 11.54%).
Surgeries were administrated for all patients, and video-
assisted thoracoscopic surgery (VATS) was the most
common procedure (n=16, 61.54%), in particular VATS
lobectomy (n=13, 50.00%). No marked pleural adhesion or
effusion was detected. Lesions were tough and well
enveloped by capsules, without apparent invasions. In
addition to one mass in the right middle and lower medias-
tinum, the other 25 masses were located in the peripheral
lung fields. Because of the erroneous intraoperative frozen
biopsy diagnosis, four subjects underwent lymph node dis-
section. Another one had an adenosquamous carcinoma in
the left upper lobe and pulmonary SH in the left lower lobe
at the same time, but the latter was a missed diagnosis
until the postoperative histopathological examination. All
patients were alive without any significant complications
by the last contact. The patient with adenosquamous car-
cinoma has been receiving chemotherapy.
Histopathological characteristics
Gross features
Gross descriptions were available for the whole speci-
mens. The maximum diameters of SH lesions varied
from 5 mm to 70 mm, average 26.85 mm. Five cases
(19.23%) were >10 mm, while another four (15.38%)
were ≥50 mm. All SH masses or nodules were well-
circumscribed and could be shelled out easily from the
surrounding pulmonary tissues. The tumors’ cut surfaces
presented as granular, rubbery, or meaty, coloring from
gray-tan, yellow to dark red.
Histologic features
Lesions were mainly composed of varying proportions of
two types of cells. The first one was epithelial cells,
which resembled type II alveolar pneumocytes. They
were coating on the surface of tumors, or the inner sur-
face of cavities, with morphologies of cubic, flat, oval, or
cylindrical appearance, called ‘lining cells’. The second
cluster was the underlayer interstitial mononuclear cells.
They are distributed in the interstitium, characterized by
uniform, medium size, and are oval or polygonal in
shape. Clear or pale staining cytoplasm, predominantly
oval nuclei with fine and evenly distributing chromatin,
occasional small nucleoli without nuclear division or ne-
crosis were frequently seen. They were described as
‘round cells’.
According to the number of tumor cells and tissue mor-
phological features, lesions included four major histological
patterns: papillary, sclerotic, solid, and hemorrhagic
(Figure 2). The papillary pattern was usually lined by small
uniform round or cuboidal cells, type II pneumocytes, and
bronchiolar epithelium, presenting as papillary appearance
instilled into the alveolar spaces or the surface of tumors.
Figure 2 Four major histologic patterns of pulmonary SH by hematoxylin-eosin stains. Pulmonary SH showed papillary (a, ×100), solid
(b, ×100), sclerotic pattern (c, ×100), and hemorrhagic (d, ×400). (e) Lining cuboidal cells and stromal round cells (×400).
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cells, even atypia or forming stratified structures. The
cuboidal cells often demonstrated multinucleation and
intranuclear inclusions, sometimes with vacuolated cyto-
plasm. Other different morphologies between the round
cells and the surface lining cells could be clear. For ex-
ample, hemosiderin was seen in the surface lining cell in
two cases, but the underlying round cells were free of such
particles.
Sclerotic foci were formed by dense interstitial fibrosis
and hyaline collagen tissues in the alveolar intervals,
often adjacent to hemorrhagic areas or solid zones.
Small sclerosed blood vessels and scattered round tumor
cells were easily found.
The solid pattern was composed of sheets of uniform
round to polygonal cells with round or oval nuclei, which
were centrally located, but mitotic figures were rare. The
round cells were lined by cuboidal cells with smaller and
darker nuclei. They demonstrated entrapped alveolar
spaces with residual reactive alveolar lining cells. Focally
accumulated foam cells, singly or clusteringly distributed
erythrocytes were also commonly interspersed around the
round cells to form small blood lakes.
Hemorrhagic lesions were filled with vascular-like chan-
nels or true vasculars. They were large, irregular, and di-
lated, packed with varying amounts of erythrocytes. A
single layer of cuboidal cells or flat cells such as endothe-
lium were lined in the walls of channels, some of which
had hyalinosis. Typical round cells were always in the
interstitium.Among the 26 cases, all tumors composed of more than
one histologic pattern. The majority (n=15, 57.69%) dem-
onstrated a variable proportion of the whole four patterns.
Nine tumors (34.62%) were composed of three patterns,
including papillary, sclerotic, and solid (n=5, 19.23%), pap-
illary, sclerotic, and hemorrhagic (n=2, 7.69%) and the
remaining two were papillary, hemorrhagic, and solid, and
hemorrhagic, sclerotic and solid, respectively. The add-
itional two cases (7.69%) contained a mixture of two pat-
terns: papillary with sclerotic for one subject and papillary
with hemorrhagic for the rest.
All pathological findings, including the additional fea-
tures, are listed in Table 2. Focal chronic inflammation,
such as interstitial fibrosis and lymphocytic infiltration,
was displayed in all cases. Hemosiderin in the alveolar
spaces or interstitium was a common appearance. Another
distinctive feature of 17 cases was the varying degrees of
atypia, leading to an erroneous intraoperative frozen bi-
opsy diagnosis of adenocarcinoma, adenosquamous car-
cinoma, and bronchioloalveolar carcinoma in four cases.
We experienced one unusual case with more than one
nodule and masses in the left lower lobe with diameters
from 8 mm to 30 mm. Only the largest one was detected
on CT scans and identified as adenocarcinoma in the
intraoperative frozen biopsy. However, further examination
confirmed the pulmonary SH for the small nodule of ap-
proximately 8 mm and other lesions. Moreover, another
subject held two masses in the left lower and upper lobes.
Pathological evidence revealed the former one was pul-
monary SH, rather than the metastatic lesion for the
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diagnosed from clinical information.
Fortunately, no lymph nodule was detected with pul-
monary SH metastasis.
Immunohistochemistry
Thirteen cases underwent immunohistochemistry with a
variable number of antibodies to determine the pheno-
type of tumor cells. The results are shown in Table 3.Table 3 Immunohistochemical findings of 13 cases of pulmon
Markers Antibodies Cases exami









Vascular-endothelial markers CD34 3
Myoepithelial markers Desmin 1
Proliferation markers Ki-67 4
aNumber of cases revealing positive results.
bProportion of positive cases to the whole examined ones.
cThe expression of Ki-67 in all positive cases was <5%.Both surface lining cells and round cells were
diffusedly strongly stained with EMA (100.00%). The lin-
ing cells were in a cytoplasmic positivity, and the round
cells displayed the main immuoreaction in membrane.
Compared with negative reaction for round cells with
PCK (0.00%), CK (0.00%), and CK-7 (25.00%), stains of
PCK, CK, CK-7, EMA, and TTF-1 were completely posi-
tive (100.00%) in all tested lining cells without exception
(Figure 3). Although the nuclear stains of TTF-1 in
round cells were a little weaker than those of lining cells,
they were all met with the positive standard, and in focal
to extensive stains. Nevertheless the number of cases
stained by the neuroendocrine markers of Syn, CgA, S-
100 and NSE, and myoepithelial markers of desmin was
limited, no positive finding in all tumor cells was still a
meaningful result. One case with a strong appearance of
EMA test exhibited a faint detection of the vascular-
endothelial marker of CD 34, but the negative trend of CD
34 staining in other specimens was still significant. In spite
of the positive expression of Ki-67 in round cells in four
tumors, it was extremely rare to scattered but never nu-
merous. The positive proportion only ranged from 1% to
5%. Moreover, it failed to stain the all lining cells.
Discussion
Pulmonary SH is an uncommon, but histologically dis-
tinctive neoplasm of the lung. Although several re-
searches have been conducted for its morphology, the
histogenesis is still contested. The most meaningful find-
ing of the current immunohistochemical study was the
completed positive reaction of EMA and TTF-1 both
with the lining cells and round cells. Other epithelial
markers, such as CK, CK-7 and PCK, also disclosed full
stains with the lining cells. The consistent outcomesary SH
ned (n) Lining cells (na, %b) Round cells (na, %b)
12 (100.00%) 12 (100.00%)
7 (100.00%) 0 (0.00%)
5 (100.00%) 0 (0.00%)
8 (100.00%) 2 (25.00%)
10 (100.00%) 10 (100.00%)
0 (0.00%) 0 (0.00%)
0 (0.00%) 0 (0.00%)
0 (0.00%) 0 (0.00%)
0 (0.00%) 0 (0.00%)
1 (33.33%) 0 (0.00%)
0 (0.00%) 0 (0.00%)
0 (0.00%) 4 (100.00%)c
Figure 3 Immunohistochemistry of pulmonary SH by the labeled streptavidin-biotin peroxidase technique. Immunohistochemical stains
showed both lining cells and round cells were positive for EMA (a, ×400) and TTF-1 (b, ×200). The lining cells were positive for CK (c, ×200),
CK-7 (d, ×200) and PCK (e, ×200).
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late that epithelial cells were the origin of pulmonary SH
tumor cells, but also indicated these antibodies were ef-
fective approaches for the diagnosis of this lesion.
TTF-1, also known as Nkx2.1, is a 38-kd homeodomain
containing DNA-binding protein expressing in the thyroid
epithelium, ventral forebrain, and bronchial epithelial cells
[11]. It is also essential for determining the pulmonary
morphogenesis and gene expression [12]. Currently, TTF-
1 has been widely used as the specific marker for type II
pneumocyte in studies of respiratory cancers. The positive
result of TTF-1 in this cohort of tumors suggests that pul-
monary SH is probably derived from alveolar epithelium.
TTF-1 in the lung also regulates the surfactant proteins,
which are a family of important innate immunity effectors
and critical for lung stability and lung host defenses [11].
Co-expression of TTF-1 and surfactant proteins is usually
detected in health adult bronchioles, alveolar epithelum,
and well-differentiated differentiated adenocarcinoma [13].
EMA is generally assumed to be expressed only on a
wide variety of human non-squamous epithelial surfaces
[14-16]. CK is another kind of scaffold protein in epithe-
lial cells. The expression of CK always can be detected
in the whole process of cells differentiation or even car-
cinogenesis. In particular, it contains series of members
with different molecular weights from 40 KD to 70 KD,
each of them suggesting a specific feature for the target
cells. In this study, apart from two cases with positive re-
action of CK-7 in round cells, other round cells revealeduniformly negative expression of PCK and CK. However,
lining cells were strongly immunoreacted with CK, PCK,
and CK-7. This immunophenotype provides insights into
the further possible discrepant cellular differentiation be-
tween the two kinds of cells. Lining cells appears to be
more differentiated than round ones. A microdissection
study also demonstrated the similar clonality of lining
cells and round cells in pulmonary SH, but they repre-
sented a variable differentiation from the same progenitor
cell [17]. Furthermore, the lack reaction of Syn, CgA, S-
100, NSE, CD34, and Desmin supported the origin of
tumor cells from pulmonary epithelium, rather than neu-
roendocrine, vascular-endothelium, or myoepithelium.
Although pulmonary SH is regarded as a benign
tumor, rare cases revealed metastasis, especially involv-
ing mediastinal or hilar lymph nodules [18-20]. However,
the distant hematogenous metastasis has never been
reported until now. Kim and colleagues [20] assumed
that the larger size of primary tumors and male patients
were more likely to have metastasis, which has not been
proved by sufficient statistical data yet. But the follow-
up information for cases over 3 years showed no appar-
ent effects on the prognosis [21-24]. In this study, we
found no metastatic cases after complete excision of tu-
mors. In spite of inadequate follow-up intervals, it was
probably a piece of evidence for the inactive biologic be-
haviors of pulmonary SH. Besides, the expression of Ki-
67 in lining cells was completely negative, and for the
round cells, only <5% ones weakly expressed it as well.
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a solitary mass. Multiple or bilateral lesions were rarely
described [25,26] and the possible pathogenesis was un-
clear. In our series, there were two cases with more than
one mass on CT scans. Pathological examinations con-
firmed one patient suffered from adenosquamous carcin-
oma in the left upper lobe and pulmonary SH in the lower
lobe, whereas the other one had bilateral lesions in both of
the lung fields. We did not investigate whether this was a
multicentric origin of pulmonary SH case or intrapulmonary
metastasis. Moreover, atypical alveolar hyperplasia (AAH)
is considered to be associated with the incidence of mul-
tiple SH lesions [21]. The specific mechanism is needed to
be explored.
Similarly to pulmonary SH, bronchioloalveolar carcin-
oma (BAC), a subtype of pulmonary adenocarcinoma, is
another tumor derived from alveolar epithelial cells,
which has been confirmed by molecular genetic tech-
niques already [27]. The differential diagnosis of pulmon-
ary SH and BAC is important. Based on its pathological
features, there are two types of BAC, the mucinous
tumor and non-mucinous tumor. The former is charac-
terized by mucus cells and mucus lakes, leading an easy
pathological identification, while the tumor cells for non-
mucinous BAC show an alveolar cell differentiation.
However, larger cell sizes, with deeper nuclear chromatin
stainings, much more marked pleomorphism and even
pathologic mitosis, makes BAC different from pulmonary
SH. For atypical cases of pulmonary SH, positive expres-
sion of EMA drawing the outline tumors cells helps to
confirm the diagnosis as well. Also, positive stainings
with antibodies of cyclinD1 and eukaryotic initiation fac-
tor 4E (eIF4E) have been recommended for the diagnosis
of BAC [28].
As a pulmonary neoplasm, SH is frequently presented in
the lung fields. Unusual cases of extralobar pulmonary SH
have been reported by Ahmetoglu [26] and Sakamoto [29].
There were three hypotheses to explain these findings
[21,26]. The first one was that the extrapulmonary lesions,
such as mediastinal masses, were metastatic foci of the pri-
mary pulmonary lesions. Second, tumors might derive
from the ectopic lung tissues. Third, the SH developed as a
pedunculated pleural mass from the lung and moved to-
wards the lung surface or mediastinum. But none of them
has been confirmed. We discovered one patient with a
mass of approximately 54 mm with heterogeneously en-
hancement on enhanced CT scans and right atrium was
extrusion. The initial diagnosis was the usual lung cancer
or other mediastinal tumors. Intraoperative frozen examin-
ation identified the diagnosis of pulmonary SH. Following
careful reviews of the chest radiological images revealed
that the tumor arose from the periphery of the lung and
developed into the central of mediastinum, giving a false
impression of lung cancer or mediastinal neoplasm.Conclusion
In conclusion, pulmonary SH is a unique neoplasm of the
lung. Solitary masses or nodules in the lung fields, espe-
cially in the right middle lobes, without apparent metastatic
lesions, are the most common radiology manifestation.
Surgical resection can obtain histopathological specimens
and cure the disease. The tumor cells include typical super-
ficial lining cells and underlying round cells, which might
origin from the pulmonary epithelial cells, characterized by
the positive staining of epithelial markers, such as EMA
and TTF-1. But the pathological mechanisms are needed to
be further elucidation.
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